Phase II trial of capecitabine and oxaliplatin in patients with advanced or metastatic pancreatic adenocarcinoma No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...
Trastuzumab + fluoropyrimidine maintenance in the frontline setting for non-progressing advanced HER-2 positive gastroesophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results